eAdvantage

Natural health product licensed in Canada

Licence holder

eAthlete Labs

NPN or DIN-HM

80081627

Status

Active licence

Licence date

1 December 2017

Revision date

Not provided

Form

Capsule

Route of administration

Orale

Application type

Non traditionnelle

If this product were sold in France

• Dose déclarée au-delà d'une limite

  Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• Dose déclarée au-delà d'une limite

  Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• À vérifier

  Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.

  limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.

• Conditions légales

  Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Non-medicinal ingredients

Stéarate de magnésium, Hypromellose, Cellulose microcristalline

Recommended doses in Canada

Uses authorised in Canada

Helps to temporarily promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue. Helps to enhance cognitive function and/or memory in adults. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates. Helps the body to metabolize fats. Helps the body to metabolize proteins. Helps to form red blood cells. Helps in tissue formation. Helps in the development and maintenance of bones. Helps in the development and maintenance of teeth. Helps in the absorption and use of calcium. Helps in the absorption and use of phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

• Précautions et mises en garde

  Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner for use beyond 6 weeks. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures.

• Effets indésirables connus

  Hypersensitivity/allergy is known to occur, in which case, discontinue use.

• Contre-indications

  Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.

Source

Official Health Canada record, licence 80081627

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.